ALT5 SIGMA News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

13.05.24	JanOne To Buy Block Chain Fintech Provider ALT 5 Sigma In All-stock Deal; JAN Up In Pre-market (RTTNews)
21.09.23	JanOne to Present at the Dawson James 8th Annual Investment Conference (PR Newswire)
31.08.23	JanOne to Present In Person and by Video at H.C. Wainwright's 25th Annual Global Investment Conference (PR Newswire)
29.08.23	JanOne Earns US Patent for the Use of its Novel Formulation of Low-Dose Naltrexone, Jan123, to Treat Chronic Pain (PR Newswire)
25.08.23	JanOne Wins "Best Abstract" Award at the Ohio Society of Interventional Pain Physicians Annual Meeting (PR Newswire)
22.08.23	JanOne Technologies Announces Closing of Registered Direct Offering Priced At-The-Market under Nasdaq Rules (PR Newswire)
19.08.23	JanOne Technologies Announces Registered Direct Offering Priced At-The-Market under Nasdaq Rules (PR Newswire)
18.08.23	JanOne to Present Prior Phase II Data on Diabetic Neuropathy at the Ohio Society of Interventional Pain Physicians Annual Meeting (PR Newswire)
28.06.23	JanOne Files Intl Patent Application For Low Dose Naltrexone For Chronic Pain (RTTNews)
28.06.23	JanOne files international patent application for methods of using low dose naltrexone to treat chronic pain (PR Newswire)
18.04.23	JanOne Completes Pre-IND Meeting with FDA on Jan123 (PR Newswire)
13.04.23	JanOne to Present Data On Its Two Non-Opioid Drug Candidates at The Appalachian Region Spine and Pain Meeting on Drug Development Programs to Treat Pain on April 15, 2023 (PR Newswire)
24.03.23	JanOne Technologies Announces Closing of Registered Direct Offering of Common Stock Priced At-The-Market (PR Newswire)
23.03.23	JanOne Welcomes John Bonfiglio -- Veteran Biotech Executive, Deal Maker and Strategist -- to Top Management Team (PR Newswire)
23.03.23	JanOne Technologies Announces Registered Direct Offering of Common Stock Priced At-The-Market (PR Newswire)
22.03.23	JanOne Sells Legacy Business ARCA Recycling to Concentrate on Growing BioPharm Businesses (PR Newswire)
22.02.23	JanOne to Present Important Trial Results at Annual Meeting of American Society of Interventional Pain Physicians (PR Newswire)
26.01.23	JanOne Charts Ambitious Strategic Course for Non-Addictive Pain Management (PR Newswire)
10.01.23	JanOne Inc. Completes Acquisition of Soin Therapeutics, LLC (PR Newswire)
21.10.22	Pre-market Movers: IMUX, ARC, SNAP, VRE, JAN… (RTTNews)
16.09.22	JanOne Inc. Executes Term Sheet to Acquire Soin Therapeutics LLC (PR Newswire)
05.07.22	ARCA Recycling, a Subsidiary of JanOne Inc., Unveils New Logo and Website (PR Newswire)
28.06.22	JanOne Inc. Announces an Improved Formulation of JAN101 (PR Newswire)
09.06.22	ARCA Recycling, Inc., a Subsidiary of JanOne Inc., Opens Three New Recycling Centers in Washington, California and New Jersey (PR Newswire)
07.06.22	JanOne Inc. Announces the Issuance of U.S. Patent Covering a Method of Improving Nerve Function Using JAN101 (PR Newswire)
01.06.22	Pre-market Movers: TNXP, CNCE, TXMD, JAN, BFI… (RTTNews)
31.05.22	JanOne Sells GeoTraq to SPYR Technologies in a $13.5 Million Transaction (PR Newswire)
04.01.22	JanOne Inc. Develops Plan for Treating Methamphetamine Use Disorder (PR Newswire)
16.12.21	ARCA Recycling, a Subsidiary of JanOne Inc., Awarded Recycling Contract in Virginia and North Carolina With Total Estimated Value of $1.6 Million for Work through 2023 (PR Newswire)
07.12.21	JanOne Inc. Acquires an Option for the Rights to a Worldwide, Exclusive License for a Novel Strategy for Treating Methamphetamine Use Disorder (PR Newswire)
27.10.21	ARCA Recycling, a Subsidiary of JanOne Inc., Launches Two Recycling Programs in California in Effort to Reduce GHG Emissions (PR Newswire)
19.10.21	ARCA Recycling, a Subsidiary of JanOne Inc., Sees Major Increase in Appliance Replacement Contracts, Estimated to Push Revenue of Replacement Programs to Nearly $20 Million, in Addition to Recycli... (PR Newswire)
12.10.21	ARCA Recycling, a Subsidiary of JanOne Inc., Opens Recycling Center in Michigan to Support New Multi-Year Contracts Totaling Millions in Revenue (PR Newswire)
07.10.21	ARCA Recycling, a Subsidiary of JanOne Inc., Awarded Recycling Contracts in Pennsylvania With Total Estimated Value of 20 Million Dollars for Work in the State to Continue Through 2026 (PR Newswire)
30.09.21	ARCA Recycling, a Subsidiary of JanOne Inc., Opens New Pennsauken, NJ, Recycling Center, Launches New Recycling Programs (PR Newswire)
28.09.21	JanOne Encouraged By Recent FDA Communications Regarding Phase 2B Clinical Trial Design of Lead Drug Candidate JAN101 (PR Newswire)
22.07.21	JanOne Selects CPC Clinical Research as Trial Manager for Phase 2b Study of JAN101 for Peripheral Artery Disease Patients (PR Newswire)
23.06.21	JanOne Readies Clinical Supply of Lead Product Candidate JAN101 for Distribution to Phase 2b Trial Sites (PR Newswire)
22.06.21	JanOne Selects Regulatory Partner for Phase 2b Trial as Investigational Plan is Prepared for FDA Filing (PR Newswire)
15.06.21	JanOne Appoints Internationally Renowned Expert on Addiction Nicholas Goeders, Ph.D. to Scientific Advisory Board (PR Newswire)
10.06.21	JanOne Engages DC Consulting LLC for Government and Private Sector Initiatives (PR Newswire)
08.06.21	JanOne Advances Toward Initiation of Phase 2b Peripheral Artery Disease (PAD) Trial for Lead Product Candidate JAN101 (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	82.24	2.93 %	K V
Part Grp Hldg	1’404.00	1.67 %	K V
CieFinRichemont	170.10	1.10 %	K V
Kuehne+Nagel Int	206.60	0.98 %	K V
Holcim	89.82	0.92 %	K V
ABB	53.58	0.04 %	K V
Givaudan	3’941.00	-0.10 %	K V
Geberit	498.50	-0.46 %	K V
Alcon	80.46	-0.54 %	K V
Sonova Hldg	314.80	-1.16 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu ALT5 SIGMA

Aktien Top/Flop

Meistgelesene Nachrichten